Next, we analyzed the effect of treatment with Gua, Ade, Cyt, and Uri in a surrogate single cycle infection model, taking advantage of spread-deficient bona fide HCV virions bearing a luciferase reporter gene (trans-complemented HCV particles, HCVtcp). The gene discussed is DDX21; the disease is infection.